Greencore Group PLC (LON:GNC) Received GBX 138.00 Target From Numis; STADA ARZNEIMITTEL AG NAMEN AKT GERMANY (STDAF) Shorts Lowered By 20%

Greencore Group PLC (LON:GNC)‘s rating was decreased by professional analysts at Numis to a Hold rating in a a report issued to clients and investors on Wednesday morning. The firm currently has a GBX 138.00 PT on the stock. Numis’s PT gives a potential upside of 7.12%.

STADA ARZNEIMITTEL AG NAMEN AKT GERMANY (OTCMKTS:STDAF) had a decrease of 20% in short interest. STDAF’s SI was 2,000 shares in March as released by FINRA. Its down 20% from 2,500 shares previously. With 100 avg volume, 20 days are for STADA ARZNEIMITTEL AG NAMEN AKT GERMANY (OTCMKTS:STDAF)’s short sellers to cover STDAF’s short positions. The SI to STADA ARZNEIMITTEL AG NAMEN AKT GERMANY’s float is 0.02%. It closed at $106.55 lastly. It is down 0.00% since March 14, 2017 and is . It has underperformed by 16.70% the S&P500.

STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of active pharmaceutical ingredients for the health care and pharmaceutical markets worldwide. The company has market cap of $6.61 billion. It operates through two divisions, Generics and Branded Products. It has a 56.35 P/E ratio. The Generics segment provides various generic active ingredients, including Tilidine naloxone for pain; Atorvastatin for elevated cholesterol levels; Pantoprazole for stomach ulcer/reflux; Diclofenac for pain/inflammation; and Enalapril for high blood pressure indications.

Among 12 analysts covering Greencore Group PLC (LON:GNC), 10 have Buy rating, 0 Sell and 2 Hold. Therefore 83% are positive. Greencore Group PLC has GBX 450 highest and GBX 150 lowest target. GBX 279.60’s average target is 118.27% above currents GBX 128.1 stock price. Greencore Group PLC had 126 analyst reports since July 23, 2015 according to SRatingsIntel. Berenberg maintained the shares of GNC in report on Friday, May 26 with “Buy” rating. The company was maintained on Tuesday, November 24 by Peel Hunt. Whitman Howard maintained it with “Buy” rating and GBX 310 target in Tuesday, August 1 report. The rating was maintained by Goodbody on Monday, September 7 with “Buy”. Goodbody maintained the stock with “Buy” rating in Thursday, July 23 report. As per Wednesday, February 24, the company rating was maintained by Investec. The rating was maintained by Peel Hunt with “Buy” on Wednesday, March 29. Berenberg maintained the shares of GNC in report on Thursday, November 26 with “Buy” rating. The rating was upgraded by Peel Hunt on Monday, November 14 to “Buy”. The rating was maintained by Shore Capital on Tuesday, January 30 with “Buy”.

Analysts await Greencore Group plc (LON:GNC) to report earnings on April, 17. They expect $0.18 earnings per share, down 51.35% or $0.19 from last year’s $0.37 per share. GNC’s profit will be $1.27M for 177.92 P/E if the $0.18 EPS becomes a reality. After $0.25 actual earnings per share reported by Greencore Group plc for the previous quarter, Wall Street now forecasts -28.00% negative EPS growth.

Greencore Group plc produces and sells various food products primarily in the United Kingdom and the United States. The company has market cap of 905.03 million GBP. It operates in through, Convenience Foods, and Ingredients and Property. It has a 67.42 P/E ratio. The firm provides sandwiches, wraps, rolls, sub-rolls, flatbreads, baguettes, bagels, prepared salads, and sushi products; and prepared meals, such as chilled ready meals, chilled sauces and soups, and quiches.